New FDA Draft Guidance Signals Acceptance of Decentralized Trials (When Done Right) – MedCity News
When regulators speak, we listen.
Naturally risk-averse industries like the life sciences need health authority acceptance before trying new approaches and especially before committing to wholesale operational change, even if the outcome has great potential….